Skip to main content

Research News

Crack GPAT — Prepare for GPAT Online 
  • A new study has revealed that taxol can also be derived from a kind of microbial 'bandage' that protects these trees from disease-causing fungi. This finding may lead to a less expensive synthetic process for making more of the cancer-fighting substance. The study appeared in Current Biology.

  • A study from 20 countries other than the United States has revealed that people who are treated for addiction are far more likely to smoke. The research team found that people in addiction treatment programs around the world use tobacco at two to three times the rate of people who are not being treated for addiction. The study is published in Addiction.

    [adsense:336x280:8701650588]

  • Researchers have created smarter immune cells that produce and deliver a healing protein to the brain while also teaching neurons to begin making the protein for themselves. The study was published in PLOS One.

    [adsense:336x280:8701650588]

  • A new study warns that if you often feel dizzy, faint or light-headed after getting up, these symptoms could indicate greater risk of developing brain disease such as Parkinson's or dementia, and even an increased risk of death. The findings appeared in the online issue of the journal Neurology.

  • New research suggests that some, but not all adults who have experienced sexual or physical abuse as children go on to develop long term depression, this could partly be due to their specific genetic make up. Researchers also found that the same gene variant that can make a person sad in one context, can trigger happiness in another context. The research was published in the British Journal of Psychiatry Open.

  • GE Healthcare announced that the US Drug Enforcement Administration (DEA) has removed the compound ioflupane I 123 from the schedules of the Controlled Substance Act, which has resulted in the descheduling of DaTscan™ (Ioflupane I 123 Injection). DaTscan is the FDA-approved imaging agent which provides an assessment of the integrity of the striatal dopaminergic system via the dopamine transporter to help physicians determine whether patients have essential tremor (ET) or a parkinsonian syndrome (PS) movement disorder such as Parkinson’s disease (PD). The action may help ensure that more healthcare providers and patients with a suspected PS or ET across the United States will have access to imaging with this agent.

    [adsense:336x280:8701650588]

Subscribe to Research News